Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Hikma Pharmaceuticals Plc (HIK:LON) | 1,610 -402.4 (-1.5%) | Mkt Cap: 3,571m
Kamla Singh
2 pages
Hikma maintains FY 19 guidance in the Q1 trading update. Not much is disclosed in the trading update, but guidance implies 0-4% growth for FY 19.
Companies: KOO MYE0 GNS FDBK AMS SN/ EKF ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC OPT
Companies: Hikma Pharmaceuticals Plc
Companies: MYE0 EKF HIK COG HVO OXB DXRX AREC
